CSL Malaysia Aleviate Human Coagulation Factor VIII 500IU/von Willebrand factor 1200IU complex, Powder for injection (50 IU/mL F

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

Von willebrand factor, Quantity: 1200 IU; Factor VIII, Quantity: 500 IU

から入手可能:

CSL Behring Australia Pty Ltd

INN（国際名）:

Factor VIII,Von willebrand factor

医薬品形態:

Injection, diluent for

構図:

Excipient Ingredients: water for injections

投与経路:

Intravenous

パッケージ内のユニット:

500 IU FVIII/1200 IU VWF

処方タイプ:

(S1) This Schedule is intentionally blank

適応症:

Aleviate is indicated for: ? the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von Willebrand disease when desmopressin (DDAVP) treatment is ineffective or contraindicated. ? the prophylaxis and treatment of non-surgical and surgical bleeding associated with FVIII deficiency due to haemophilia A.

製品概要:

Visual Identification: Clear colourless solution free from visible particles.; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

認証ステータス:

Listed (Export Only)

承認日:

2014-12-16